BMS CCR2 22

Overview

BMS CCR2 22 is a potent, specific and high affinity CC-type chemokine receptor 2 ( CCR2 ) antagonist with excellent binding affinity (binding IC 50 of 5.1 nM) and potent functional antagonism (calcium flux IC 50 of 18 nM and chemotaxis IC 50 of 1 nM).

Application

Products | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Pulmonary Disease | Products > Disease Areas > Autoimmune Disease | Products > Disease Areas > Arthritis | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Lung Fibrosis | Products > Disease Areas > Rheumatoid Arthritis | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Musculoskeletal and Skin Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Endocrinology | Products > Signaling Pathways > CCR

Product Information

• Catalog No.: HY-101908
• CAS No.: 445479-97-0
• Molecular Formula: C28H34F3N5O4S
• Molecular Weight: 593.66
• Purity: 99.27%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.08 mg/mL (3.50 mM); Clear solution
• Availability: In-stock

Source

Original product source